ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SDI Sdi Group Plc

71.50
2.50 (3.62%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sdi Group Plc LSE:SDI London Ordinary Share GB00B3FBWW43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 3.62% 71.50 71.00 72.00 74.00 69.50 69.50 1,046,525 15:22:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 67.58M 3.87M 0.0372 19.22 74.4M
Sdi Group Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker SDI. The last closing price for Sdi was 69p. Over the last year, Sdi shares have traded in a share price range of 51.50p to 156.00p.

Sdi currently has 104,050,044 shares in issue. The market capitalisation of Sdi is £74.40 million. Sdi has a price to earnings ratio (PE ratio) of 19.22.

Sdi Share Discussion Threads

Showing 76 to 100 of 4075 messages
Chat Pages: Latest  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
06/9/2013
16:26
Looks like share magazine has already generated some interest here.
nick2008
06/9/2013
13:24
The thing that may hold this back sadly is that it can be quite hard to trade online.
xlairways
06/9/2013
09:12
Yeap! Saw the article in the shares magazine. Till date no one knows this stock outside of Advfn - so tip in shares magazine is a welcome news.
nick2008
05/9/2013
14:45
Tipped in the shares magazine today. Should give this some interest over the weekend :-)
xlairways
29/8/2013
08:30
AGM notice RNS - change in the venue.
nick2008
12/8/2013
00:06
Cheers Woody - I'll take a look at CRX in the morning.
masurenguy
09/8/2013
18:23
Mas

nice to have you here too, i've had a nibble but like you will pyramid (as is my normal investment style) on news and eps growth.I'll assume the CEO reasons for limited holding are genuine.

No advice intended but have a look at CRX it's a little ahead of SDI in it's development imv. I've a larger holding in CRX than SDI at present but i see both as very good potential for growth.

WC

woodcutter
09/8/2013
16:57
Thanks Nick - I've responded to your message.
masurenguy
09/8/2013
13:44
MasurenguyCheck your PM message. Nick.
nick2008
09/8/2013
13:39
Woodcutter , MasurenguyWelcome guys - good to have you both on this thread. Masurenguy - I spoke to CEO earlier this year regarding his buying of stock and he gave a genuine reply which I can't post here. I'll private message it across to you. This is really the beginning - the new ProReveal will become the standard across 250 hospitals in the UK. Just imagine the potential across the world. DYORNick.
nick2008
09/8/2013
12:52
Interesting company. Joined AIM in Dec 2008 raising £2m @an IPO price of 12.5p. Since then they have issued 1.3m shares in acquiring Artemis and undertaken a placing of a further 4.8m shares in June @15p. This was to raise a further £850K in order to retire a convertible loan of £380k and to acquire more working capital. Current market cap is £4.3m based upon 24.2m shares in issue.

Their eps is around 1p and they had a positive net cash balance of just under £400K at their April year end. Chairman Ford recently bought 100,000 shares @16.5p but I'd like to see the CEO buy a bigger stake since a total holding of 7,500 shares is hardly inspiring. The business is nicely geographically segmented with circa 30% in the US, 30% in Europe (ex-UK), 25% in Asia and 10% in the UK although that should increase further following the recent adoption of ProReveal at Eastwood Park.

On to my Watchlist at this point as it looks as though it may be on the cusp of some accelerated growth.

masurenguy
06/8/2013
11:50
Had a little nibble here today. Prospects look very interesting and if the forecast are to be believed and achieved then it looks very undervalued particularly with market leading position on some of it's products.

If ProReveal sells at anything like it's potential it should multibag from here. And there does seem to be a good global distribution set up too.

Although cash flow from operations was decent there's not a lot of cash on the balance sheet even allowing for the placing and loan repayment so managing the working capital requirements is going to be very important.

The only down side i can see is the spread and illiquidity but that may well work in our favour if the mm's become short of stock. We may see a further placing possibly dependant on cash flows and WC requirements.

One to put away for the longer term perhaps and maybe build as time goes on.

Woody

woodcutter
26/7/2013
10:59
Their main product which will sell like hot cakes is ProReveal.

See this article from Journal of Hospital published earlier this year


This confirms that Ninhydrin kits, currently used in hospitals are ineffective at detecting residual proteins. The way forward is SDI ProReveal which has got the first mover advantage.

nick2008
26/7/2013
08:05
Good morning all
nick2008
25/7/2013
17:25
Strange !! There is a buy at 21p - single buy trade yet the price drops down.
nick2008
25/7/2013
14:59
Extracts from Results

- We believe that the recent SFDA order independently validates our technology as the "gold standard" and consider that our growth in Asia will continue to be fuelled by their need for excellent automation in the life sciences.


- ProReveal is the only technology currently available that can meet nanogram levels of detection and could potentially be installed in 300 SSD's, in hospitals and private decontamination companies throughout the UK.


- In 2013, 10 ProReveal systems were sold in the UK and Synoptics Health's UK distributor has installed three ProReveal systems in two major SSD's of leading London hospitals and one in an NHS training facility.


- Synoptics Health is currently enjoying a first mover advantage in this untapped healthcare market sector not just in the UK but internationally.

- During the period, the Synoptics Health Division appointed a network of six new distributors throughout the Asia-Pacific region

- In Europe, the Division has appointed a new distributor in Germany and sold four systems, which are being independently evaluated by German hospitals. There are plans to have Dutch and Italian distributors in place, as well as a North American distributor within the next few months ensuring growth in demand for the ProReveal viewer and more importantly, a recurring revenue stream for the ProReveal spray over the coming year.

nick2008
25/7/2013
14:53
Wow! now Mike Creedon, Chief Executive Officer of the Company buys the stock...

Note that Mike was the NEW CEO last year who has been turning around this company.

nick2008
24/7/2013
20:03
This is tightly held stock, so doesn't take much buying to push the price up. We'll see more buying this week. DYORNick.
nick2008
24/7/2013
11:08
25k buy @20p went through....
nick2008
24/7/2013
10:43
Another director buy at 16.5p. RNS out now.
nick2008
24/7/2013
10:14
Plus a very encouraging results RNS.
gnnmartin
24/7/2013
08:14
RNS out - SDI is pleased to announce that the major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to supplement the training of validation professionals on how to assess the efficacy of the decontamination processes.
nick2008
12/7/2013
23:02
Good buying today.
nick2008
28/6/2013
15:57
Strange to fall today?
nick2008
28/6/2013
14:58
hastings, thanks. I looked in today to see what's hit the shares. No news yet though. Very odd.
Nigel Martin

gnnmartin
Chat Pages: Latest  7  6  5  4  3  2  1